ICAHN CARL C
Institutional investor · Portfolio as of Q2 2019
Top Holdings16 positions
ICAHN ENTERPRISES LP DEPOSITARY UNIT | 185.3M | $13.4B | 50.6% | $14.62 | +31.54% | 3 qtrssince 2018-Q4 | Increased 69 |
CVR Energy Inc. | 71.2M | $3.6B | 13.4% | $19.52 | +50.24% | 3 qtrssince 2018-Q4 | Unchanged 0 |
OCCIDENTAL PETE CORP | 33.2M | $1.7B | 6.3% | $44.18 | 0.00% | 1 qtr | New 100 |
HERBALIFE NUTRITION LTD | 35.2M | $1.5B | 5.7% | $58.20 | -26.53% | 3 qtrssince 2018-Q4 | Unchanged 0 |
CHENIERE ENERGY INC | 21.6M | $1.5B | 5.6% | $56.31 | +15.64% | 3 qtrssince 2018-Q4 | Decreased 0 |
| 99.3M | $1.2B | 4.4% | — | — | 2 qtrssince 2019-Q1 | Unchanged 0 | |
| 23.5M | $830.6M | 3.1% | — | — | 3 qtrssince 2018-Q4 | Unchanged 0 | |
NEWELL BRANDS INC | 41.1M | $634.1M | 2.4% | $13.20 | -13.48% | 3 qtrssince 2018-Q4 | Unchanged 0 |
NAVISTAR INTL CORP NEW | 16.7M | $576.3M | 2.2% | — | — | 3 qtrssince 2018-Q4 | Unchanged 0 |
Freeport-McMoRan Inc. | 44.2M | $512.9M | 1.9% | $9.56 | +11.82% | 3 qtrssince 2018-Q4 | Decreased 0 |
HERTZ GLOBAL HLDGS INC | 24.3M | $387.3M | 1.5% | — | — | 3 qtrssince 2018-Q4 | Unchanged 0 |
CONDUENT INC COM | 31.6M | $303.4M | 1.1% | $10.22 | -6.13% | 3 qtrssince 2018-Q4 | Increased 73 |
HERC HLDGS INC COM | 4.5M | $206M | 0.8% | $23.61 | +79.54% | 3 qtrssince 2018-Q4 | Unchanged 0 |
WELBILT INC | 10.1M | $168.4M | 0.6% | — | — | 3 qtrssince 2018-Q4 | Unchanged 0 |
| 5.7M | $62.7M | 0.2% | $10.39 | +24.25% | 3 qtrssince 2018-Q4 | Unchanged 0 | |
SANDRIDGE ENERGY INC COM NEW | 4.8M | $33.3M | 0.1% | $5.53 | -8.86% | 3 qtrssince 2018-Q4 | Unchanged 0 |
ICAHN CARL C manages $26.5B across 16 positions as of Q2 2019. Top holdings: IEP (50.6%), CVI (13.4%), OXY (6.3%). Fund DNA: Concentrated Value. HoldingsIntel Score: 4/5.0.
Added 1 new position, exited 1, increased 2, trimmed 2. Top move: OXY (NEW, conviction 100). Portfolio: $26.5B across 16 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR